Ultrasound elastography is being proposed as a way to guide and monitor ablation therapy. Researchers say elastography could help ultrasound overcome limitations in this setting, and increase its visibility among other imaging modalities used for guidance.
Ultrasound elastography is being proposed as a way to guide and monitor ablation therapy. Researchers say elastography could help ultrasound overcome limitations in this setting, and increase its visibility among other imaging modalities used for guidance.
As the prevalence of liver cancer increases, physicians foresee a boom in utilization of radiofrequency and other thermal ablation procedures. Therefore, considerable procedural sophistication is needed. Ultrasound is one of the preferred imaging modalities for radiofrequency ablation guidance. However, the bubbling effect produced by thermal coagulation in tissue typically impairs sonographic visualization. Elastography helps overcome this problem by echoing tissue strain in the zone of necrosis, said Flemming Forsberg, Ph.D., a professor of radiology at Thomas Jefferson University in Philadelphia.
A research team led by James A. Zagzebski, Ph.D., and Tomy Varghese, ultrasound imaging experts in the medical physics department at the University of Wisconsin in Madison, recently unveiled results on an RFA-based technique called electrode displacement elastography. This method enhances lesion targeting by reducing sliding and motion of abdominal organs undergoing ablation. They presented their findings at the 2006 American Institute of Ultrasound in Medicine meeting in March.
"Elastographic ultrasound guidance should make procedures faster and you may get away with killing less tissue," Forsberg said. "There are still some lesions we don't see very well with ultrasound. But it becomes a trade-off when radiation is an issue. We are doing more and more ablation therapy these days. This means we could do more RFA with ultrasound that otherwise used to be performed with CT for guidance."
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.